Skip to main content

Biochemical and Morphological Abnormalities in Paranoid and Nonparanoid Schizophrenia

  • Chapter
Biological Psychiatry, Higher Nervous Activity
  • 18 Accesses

Abstract

The understanding of the biological mechanism of schizophrenia has progressed during the past three decades since the advent of antipsychotic drugs. However, the biochemical findings of the dopamine system in the central nervous system of the patients are still inconsistent. One reason for this gap is, of course, that schizophrenia itself could be a heterogeneous condition. Therefore, subjects for biological study should be chosen to represent as homogeneous a group as possible. In this sense, patients with paranoid schizophrenia form a representative group to study from the biological point of view.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. Carlsson, B. E. Roos, J. Walinder, and A. Scott, Further studies on the mechanism of antipsychotic action., Potentiation by alpha-methyl-tyrosine of thioridazine effects in chronic schizophrenia, J. Neuronal Transmission., 34: 125 (1973).

    Article  CAS  Google Scholar 

  2. R. Takahashi, S. Yoshimoto, and H. Matsumoto., Implication of plasma level of neuroleptics in the treatment and pathophysiological research of schizophrenia, in:“Cooperation Franco-Japonaise,. Colloque Psychopharmacologie,” P. Pichot, T. Kobayashi eds., Paris (1979).

    Google Scholar 

  3. R. J. Wyatt, S. G. Potkin, T. P. Bridge, B. H- Phelps, and C. D. Weise, Monoamine oxidase in schizophrenia, And overview, Schizophrenia Bulletin. 6: 199 (1980).

    Article  PubMed  CAS  Google Scholar 

  4. S. G. Potkin, H’ E. Cannon, D. L-. Murphy, and R. J. Wyatt, Are paranoid schizophrenics biologically different from other schizophrenics? The New Eng. J. Med. 298: 61 (1978).

    Article  CAS  Google Scholar 

  5. S. G. Potkin, K. Farouk, L. Chuang, H. E. Cannon-Spoor, L. Phillips, and R. J. Wyatt, Phenylethylamine in paranoid chronic schizophrenia. Science 206: 470 (1979).

    Article  PubMed  CAS  Google Scholar 

  6. R. Takahashi, Y. Inaba, K. Inanaga, N. Kato, H. Kumashiro, T. Nishimura, T. Okuma, S. Otsuki, T. Sakai, T. Sato and Y. Shimazono, CT scanning and the investigation of schizophrenia, in:“Biological Psychiatry 198,” C. Perris, G. Struve and B. Jansson, eds., Elsevier, Amsterdam (1981).

    Google Scholar 

  7. T. J. Crow, Molecular pathology of schizophrenia; more than one disease process, Br. Med. J., 280: 66 (1980)-;

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer Science+Business Media New York

About this chapter

Cite this chapter

Takahashi, R. (1985). Biochemical and Morphological Abnormalities in Paranoid and Nonparanoid Schizophrenia. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Biological Psychiatry, Higher Nervous Activity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8329-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8329-1_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8331-4

  • Online ISBN: 978-1-4684-8329-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics